epigallocatechin gallate has been researched along with Diabetes Mellitus, Adult-Onset in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (8.33) | 29.6817 |
| 2010's | 20 (55.56) | 24.3611 |
| 2020's | 13 (36.11) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, CL; Guo, SJ; Jiang, B; Li, N; Li, XQ; Shi, DY; Wang, LJ | 1 |
| Chen, J; Jia, Q; Mehmood, S; Yang, R; Yang, X | 1 |
| Ghosh, D; Jagdale, P; Kar, AK; Patnaik, S; Saji, J; Shraogi, N; Singh, A; Singh, D; Verma, R | 1 |
| Jia, Q; Li, Y; Mehmood, S; Yang, R | 1 |
| Jiang, Y; Liu, Y; Xu, H; Yu, H; Zhu, M | 1 |
| James, A; Wang, K; Wang, Y | 1 |
| Bao, J; Chen, F; Chen, J; Gan, W; Ren, K; Wang, M; Wang, T; Yu, P; Zhang, F; Zhang, Z | 1 |
| Jin, L; Liang, G; Lv, Y; Wang, Y | 1 |
| Lu, Y; Ren, Z; Yang, H; Yang, Z; Zhang, R | 1 |
| Huang, YW; Pang, QQ; Sheng, J; Wang, XJ; Yang, XY; Yu, CJ; Zhang, XJ; Zhu, QQ | 1 |
| Hou, G; Liu, H; Liu, Q; Xi, X | 1 |
| Diao, Y; Hu, X; Li, L; Li, X; Liu, H; Peng, J; Xu, Q; Yin, H; Yu, J; Zhang, C; Zhang, X; Zhang, Y | 1 |
| Wang, J; Wang, Z; Xin, C; Zhao, M | 1 |
| Alipour, M; Allivand, M; Bazyar, H; Hosseini, SA; Labibzadeh, M; Mombaini, D; Saradar, S | 1 |
| Guan, Y; Li, Y; Ling, F; Niu, Y; Wu, Y; Yuan, H; Zhang, C; Zhang, Q | 1 |
| Chen, M; Li, S; Li, X; Sun, Z; Wang, J; Xie, B | 1 |
| Casanova, E; Crescenti, A; Gibert-Ramos, A; Salvadó, J | 1 |
| Ahn, S; Bae, JH; Bae, KC; Cho, HC; Choi, YJ; Im, SS; Kim, SP; Kim, YW; Park, JH; Song, DK | 1 |
| Chan, KC; Chang, YH; Chao, YC; Huang, SM; Lai, CY; Lin, JA; Tseng, ST; Wu, CH; Yen, GC | 1 |
| Kim, JJ; Qu, X; Sun, YL; Tan, Y; Xiao, L | 1 |
| Goda, T; Mochizuki, K; Suzuki, T; Uchiyama, Y | 2 |
| Gu, D; Hu, G; Jiao, H; Ni, X | 1 |
| Keske, MA; Kim, JA; Munir, K; Ng, HL; Premilovac, D; Quon, MJ; Rattigan, S; Yang, P | 1 |
| Huang, J; Wang, Y; Yang, CS; Zhang, J; Zhang, L | 1 |
| Brender, JR; Fierke, CA; Pithadia, A; Ramamoorthy, A | 1 |
| Ishizaki, Y; Kikuzaki, H; Kobayashi, K; Kojo, S | 1 |
| Botelho, PB; de Morais, AC; Ferreira, MA; Mota, JF; Silva, DM | 1 |
| Chen, CH; He, YM; Li, ZH; Ma, GL; Xu, LH; Xu, ZX; Yang, HJ; Zhang, Q; Zhang, Y; Zhou, GR; Zhou, P | 1 |
| Cai, EP; Lin, JK | 1 |
| Abedini, A; Meng, F; Plesner, A; Raleigh, DP; Verchere, CB | 1 |
| Chou, P; Hsu, CH; Huang, CJ; Liao, YL; Lin, SC; Tsai, TH | 1 |
| Feng, Z; Liu, J; Long, J; Shen, W; Wang, Y; Weber, P; Wertz, K; Yan, J | 1 |
| Gradinaru, D; Ilie, M; Margina, D | 1 |
| Preller, M; Raederstorff, D; Riegger, C; Teixeira, SR; Wang, Y; Weber, P; Wolfram, S | 1 |
| Goda, T; Mochizuki, K; Sakurai, N; Shimada, M | 1 |
8 review(s) available for epigallocatechin gallate and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Structure-Activity Relationship | 2018 |
Therapeutic Activity of Green Tea Epigallocatechin-3-Gallate on Metabolic Diseases and Non-Alcoholic Fatty Liver Diseases: The Current Updates.
Topics: Antioxidants; Catechin; Diabetes Mellitus, Type 2; Humans; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Obesity; Polyphenols; Tea | 2023 |
Epigallocatechin Gallate Modulates Muscle Homeostasis in Type 2 Diabetes and Obesity by Targeting Energetic and Redox Pathways: A Narrative Review.
Topics: Animals; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Energy Metabolism; Epigenesis, Genetic; Glucose; Homeostasis; Humans; Lipid Metabolism; Muscle, Skeletal; NF-kappa B; Obesity; Oxidative Stress; Signal Transduction | 2019 |
Having a promising efficacy on type II diabetes, it's definitely a green tea time.
Topics: Animals; Antioxidants; Catechin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Polyphenols; Polysaccharides; Signal Transduction; Tea | 2015 |
Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate.
Topics: Adipose Tissue; Animals; Cardiovascular Diseases; Catechin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Liver; Muscle, Skeletal; Nitric Oxide; Tea | 2015 |
Mechanisms of body weight reduction and metabolic syndrome alleviation by tea.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Camellia sinensis; Cardiovascular Diseases; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Liver; Meta-Analysis as Topic; Metabolic Syndrome; Muscle, Skeletal; Plant Leaves; Polyphenols; Randomized Controlled Trials as Topic; Risk Factors; Tea; Weight Loss | 2016 |
Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives.
Topics: Catechin; Curcumin; Diabetes Mellitus, Type 2; Humans; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Resveratrol; Stilbenes | 2016 |
Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review.
Topics: Animals; Antioxidants; Body Composition; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Inflammation; Insulin Resistance; Meta-Analysis as Topic; Obesity; Oxidative Stress; Phytotherapy; Randomized Controlled Trials as Topic; Risk Factors; Tea | 2016 |
3 trial(s) available for epigallocatechin gallate and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Effects of epigallocatechin-3-gallate of
Topics: Antioxidants; Biomarkers; Blood Pressure; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Flour; Humans; Lipids; Plant Leaves; Triticum | 2020 |
EGCG-rich green tea extract stimulates sRAGE secretion to inhibit S100A12-RAGE axis through ADAM10-mediated ectodomain shedding of extracellular RAGE in type 2 diabetes.
Topics: ADAM Proteins; ADAM10 Protein; Amyloid Precursor Protein Secretases; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Female; Humans; Male; Membrane Proteins; Middle Aged; Monocytes; Plant Extracts; Protein Structure, Tertiary; Receptor for Advanced Glycation End Products; Receptors, Immunologic; S100 Proteins; S100A12 Protein | 2013 |
Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial.
Topics: Adult; Antioxidants; Body Mass Index; Catechin; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Obesity; Prospective Studies; Tea; Treatment Outcome; Waist-Hip Ratio; Weight Loss; Young Adult | 2011 |
25 other study(ies) available for epigallocatechin gallate and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Epigallocatechin-3-gallate ameliorates renal endoplasmic reticulum stress-mediated inflammation in type 2 diabetic rats.
Topics: Animals; Catechin; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Stress; Hyperglycemia; Inflammasomes; Inflammation; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Tea | 2022 |
Biopolymeric composite hydrogel loaded with silver NPs and epigallocatechin gallate (EGCG) effectively manages ROS for rapid wound healing in type II diabetic wounds.
Topics: Animals; Catechin; Diabetes Mellitus, Type 2; Hydrogels; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; Silver; Wound Healing | 2022 |
Epigallocatechin-3-gallate attenuates myocardial fibrosis in diabetic rats by activating autophagy.
Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Autophagy; Beclin-1; Blood Glucose; Catechin; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Fibrosis; Hydroxyproline; Hypertrophy; Mammals; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microtubule-Associated Proteins; Rats; TOR Serine-Threonine Kinases; Transforming Growth Factor beta1 | 2022 |
Epigallocatechin gallate inhibits SNARE-dependent membrane fusion by blocking trans-SNARE assembly.
Topics: Diabetes Mellitus, Type 2; Humans; Insulins; Membrane Fusion; SNARE Proteins | 2022 |
Beneficial effects of green tea on age related diseases.
Topics: Aging; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Functional Food; Humans; Metabolic Syndrome; Obesity; Plant Extracts; Tea | 2020 |
Revealing the Mechanism of EGCG, Genistein, Rutin, Quercetin, and Silibinin Against hIAPP Aggregation via Computational Simulations.
Topics: Catechin; Diabetes Mellitus, Type 2; Genistein; Humans; Islet Amyloid Polypeptide; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Quercetin; Rutin; Silybin | 2020 |
Anti‑glycolipid disorder effect of epigallocatechin‑3‑gallate on high‑fat diet and STZ‑induced T2DM in mice.
Topics: Animals; Blood Glucose; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Endothelial Cells; Glycolipids; Hypercholesterolemia; Hyperlipidemias; Insulin Resistance; Lipids; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Sterol Regulatory Element Binding Protein 2; Streptozocin | 2020 |
EGCG targeting Notch to attenuate renal fibrosis
Topics: Animals; Antioxidants; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Injections, Intraperitoneal; Mice; Mice, Inbred ICR; Random Allocation; Renal Insufficiency, Chronic; Signal Transduction; Smad3 Protein; Streptozocin; Transforming Growth Factor beta | 2020 |
[Effects of swimming and epigallocatechin gallate on interstitial proteins expression of myocardium from type 2 diabetic rats].
Topics: Animals; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Male; Myocardium; Rats; Rats, Sprague-Dawley; Swimming; Transforming Growth Factor beta1 | 2021 |
Epigallocatechin-3-gallate prevents inflammation and diabetes -Induced glucose tolerance through inhibition of NLRP3 inflammasome activation.
Topics: Animals; Anti-Inflammatory Agents; Bone Marrow; Catechin; Cells, Cultured; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Glucose Tolerance Test; Humans; Inflammasomes; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis | 2021 |
Hawthorn polyphenols, D-chiro-inositol, and epigallocatechin gallate exert a synergistic hypoglycemic effect.
Topics: Animals; Catechin; Crataegus; Diabetes Mellitus, Type 2; Glycogen Synthase Kinase 3; Hypoglycemic Agents; Inositol; Mice; Phosphatidylinositol 3-Kinases; Polyphenols | 2021 |
Epigallocatechin gallate improves insulin resistance in HepG2 cells through alleviating inflammation and lipotoxicity.
Topics: Animals; Catechin; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Hep G2 Cells; Humans; Inflammation; Insulin Resistance; Oxidative Stress; Rats; Transfection | 2018 |
(-)-Epigallocatechin-3-gallate (EGCG) inhibits starch digestion and improves glucose homeostasis through direct or indirect activation of PXR/CAR-mediated phase II metabolism in diabetic mice.
Topics: alpha-Amylases; alpha-Glucosidases; Animals; Camellia sinensis; Catechin; Constitutive Androstane Receptor; Diabetes Mellitus, Type 2; Gluconeogenesis; Glucose; Homeostasis; Humans; Intestine, Small; Lipogenesis; Liver; Male; Mice; Mice, Inbred ICR; Plant Extracts; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Starch; Sterol Regulatory Element Binding Protein 1 | 2018 |
Green tea extract with polyethylene glycol-3350 reduces body weight and improves glucose tolerance in db/db and high-fat diet mice.
Topics: Adiponectin; Adipose Tissue; Animals; Anti-Obesity Agents; Caco-2 Cells; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose; Glucose Intolerance; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Obesity; Organ Size; Plant Extracts; Polyethylene Glycols; Retinol-Binding Proteins, Plasma | 2013 |
Green tea polyphenol epigallocatechin-3-gallate enhance glycogen synthesis and inhibit lipogenesis in hepatocytes.
Topics: Antioxidants; Catechin; Diabetes Mellitus, Type 2; Glycogen; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Lipogenesis; Metabolic Syndrome; Phosphorylation; Proto-Oncogene Proteins c-akt; Tea | 2013 |
Dietary supplementation with (-)-epigallocatechin-3-gallate reduces inflammatory response in adipose tissue of non-obese type 2 diabetic Goto-Kakizaki (GK) rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Catechin; Diabetes Mellitus, Type 2; Dietary Supplements; Gene Expression Regulation; Inflammation; Male; Obesity; Oxidative Stress; Rats; Rats, Wistar | 2013 |
Dietary supplementation with a low dose of (-)-epigallocatechin-3-gallate reduces pro-inflammatory responses in peripheral leukocytes of non-obese type 2 diabetic GK rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Analysis of Variance; Animals; Catechin; Chemokines; Corn Oil; Cytokines; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet; Diet, High-Fat; Dietary Fats; Dietary Supplements; Disease Models, Animal; Inflammation; Leukocytes; Male; Malondialdehyde; Oxidative Stress; Polymerase Chain Reaction; Rats; Rats, Wistar | 2013 |
Strong Inhibition of Secretory Sphingomyelinase by Catechins, Particularly by (-)-Epicatechin 3-O-Gallate and (-)-3'-O-Methylepigallocatechin 3-O-Gallate.
Topics: Animals; Atherosclerosis; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Hydrogen-Ion Concentration; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sphingomyelin Phosphodiesterase | 2016 |
Influence of Aluminium and EGCG on Fibrillation and Aggregation of Human Islet Amyloid Polypeptide.
Topics: Aluminum; Amyloid; Catechin; Chelating Agents; Diabetes Mellitus, Type 2; Humans; Islet Amyloid Polypeptide; Kinetics; Light; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Scattering, Radiation; Spectrometry, Fluorescence; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2016 |
Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic beta cells.
Topics: AMP-Activated Protein Kinases; Animals; Catechin; Cell Line, Tumor; Diabetes Mellitus, Type 2; Down-Regulation; Glucose; Humans; Insulin Receptor Substrate Proteins; Insulin-Secreting Cells; Rats; Rutin; Signal Transduction | 2009 |
The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity.
Topics: alpha-Synuclein; Amyloid; Amyloid beta-Protein Precursor; Animals; Benzothiazoles; Catechin; Cell Culture Techniques; Diabetes Mellitus, Type 2; Flavonoids; Islet Amyloid Polypeptide; Microscopy, Electron, Transmission; Phenols; Polyphenols; Protease Nexins; Rats; Receptors, Cell Surface; Thiazoles | 2010 |
Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto-Kakizaki (GK) rats: ameliorating effects of (-)-epigallocatechin-3-gallate.
Topics: Animals; Autophagy; Blood Glucose; Catechin; Diabetes Mellitus, Type 2; Down-Regulation; Fasting; Hypoglycemic Agents; Insulin Resistance; Male; Mitochondria; Mitogen-Activated Protein Kinases; Muscle, Skeletal; Oxidative Stress; Rats; Tumor Suppressor Protein p53; Up-Regulation | 2012 |
Quercetin and epigallocatechin gallate induce in vitro a dose-dependent stiffening and hyperpolarizing effect on the cell membrane of human mononuclear blood cells.
Topics: Adult; Aged; Anisotropy; Biomarkers; Cardiovascular Diseases; Catechin; Cell Membrane; Cell Polarity; Diabetes Mellitus, Type 2; Diet, Vegetarian; Female; Humans; Hyperglycemia; Inflammation; Insulin; Insulin Resistance; Leukocytes, Mononuclear; Male; Membrane Fluidity; Membrane Potentials; Middle Aged; Quercetin; Resistin | 2012 |
Epigallocatechin gallate supplementation alleviates diabetes in rodents.
Topics: Acyl-CoA Oxidase; Adipose Tissue; Animals; Blood Glucose; Carnitine O-Palmitoyltransferase; Catechin; Cell Line, Tumor; Diabetes Mellitus, Type 2; Dietary Supplements; Gene Expression; Gene Expression Regulation; Glucokinase; Glucose; Glucose Tolerance Test; Lipid Metabolism; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Rats, Sprague-Dawley; RNA, Messenger | 2006 |
Dietary supplementation with epigallocatechin gallate elevates levels of circulating adiponectin in non-obese type-2 diabetic Goto-Kakizaki rats.
Topics: Adiponectin; Animals; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Lipid Metabolism; Rats; Rats, Inbred Strains; Triglycerides | 2007 |